SRPT Sarepta Therapeutics
$13.33 -5.93%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-5.93%
YTD
-38.10%
P/E
102.94
P/B
1.98
ROE
1%
Div yield
—
Beta
1.72
Market cap
$1.5B
RSI (14)
25
Next earnings
Feb 23, 2027
Same sector · Health Care
Compare SRPT with NVO and JNJ →Follow SRPT in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$13.92
Close
$13.33
Day high
$14.47
Day low
$13.25
Volume
2.2M
Latest headlines
DraftKings downgraded, Sarepta upgraded: Wall Street's top analyst calls
Yahoo Finance · Nov 10
Sarepta Therapeutics Sees Transformational 2027 as Rare Disease Programs Advance
Yahoo Finance · Nov 9
Learn Why The Bull Case For Sarepta Therapeutics Stock Could Change Following Raised Revenue Guidance
Yahoo Finance · Nov 7
Sarepta (SRPT) Q3 2026 Earnings Call Transcript
Yahoo Finance · Nov 6
Sarepta Therapeutics Q3 Earnings Call Highlights
Yahoo Finance · Nov 6
Sarepta Therapeutics (SRPT) Q3 Earnings Lag Estimates
Yahoo Finance · Nov 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 5, 2026 View → 10-Q Nov 5, 2026 View → 8-K Sep 23, 2026 View → 8-K Aug 5, 2026 View → 10-Q Aug 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell SRPT. Try it in the Lab to size a position and see the risk.